XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues [Abstract]    
Revenue $ 94,576  
Operating expenses:    
Cost of revenue (excluding amortization and depreciation) 7,556  
Research and development 17,793 $ 12,585
Selling, general and administrative 74,191 25,704
Gain in fair value of contingent consideration (162)  
Intangible asset amortization 1,572  
Total operating expenses 100,950 38,289
Loss from operations (6,374) (38,289)
Interest expense, net (2,264) (1,343)
Income before provision for income taxes (8,638) (39,632)
Provision for income taxes (2,580)  
Net loss $ (11,218) $ (39,632)
Net loss per common share, basic $ (0.26) $ (1.03)
Net loss per common share, diluted $ (0.26) $ (1.03)
Weighted average common shares outstanding, basic 43,523,631 38,323,167
Weighted average common shares outstanding, diluted 43,523,631 38,323,167
Product Sales    
Revenues [Abstract]    
Revenue $ 28,569  
License Revenue    
Revenues [Abstract]    
Revenue 65,735  
Royalty Revenue    
Revenues [Abstract]    
Revenue $ 272